Pulike Biological Engineering Inc
SSE:603566
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
CN |
|
G
|
Grand Korea Leisure Co Ltd
KRX:114090
|
KR |
|
Innovid Corp
NYSE:CTV
|
US |
|
C
|
Cultural Investment Holdings Co Ltd
SSE:600715
|
CN |
|
W
|
Wizz Air Holdings PLC
OTC:WZZZY
|
CH |
|
C
|
CITIC Ltd
OTC:CTPCY
|
CN |
|
F
|
Fulongma Group Co Ltd
SSE:603686
|
CN |
|
S
|
Shanghai Smart Control Co Ltd
SZSE:001266
|
CN |
|
Hong Kong Finance Group Ltd
HKEX:1273
|
HK |
|
K
|
Kawasaki Kisen Kaisha Ltd
TSE:9107
|
JP |
|
Chungho ICT Co Ltd
KRX:012600
|
KR |
|
S
|
Sampo plc
XBER:SMPA
|
FI |
|
BGF Retail Co Ltd
KRX:282330
|
KR |
|
MPC Muenchmeyer Petersen Capital AG
XETRA:MPCK
|
DE |
|
Fortis Inc
TSX:FTS
|
CA |
|
E
|
Eupe Corporation Bhd
KLSE:EUPE
|
MY |
|
Allegiant Travel Co
NASDAQ:ALGT
|
US |
|
LookSmart Group Inc
OTC:LKST
|
US |
|
IFCI Ltd
NSE:IFCI
|
IN |
|
Centrais Eletricas Brasileiras SA
NYSE:EBR.B
|
BR |
|
X
|
Xin Hwa Holdings Bhd
KLSE:XINHWA
|
MY |
|
Genesis Healthcare Inc
OTC:GENN
|
US |
Pulike Biological Engineering Inc
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
